195 related articles for article (PubMed ID: 19372222)
21. Mechanism of action of progesterone antagonists.
Leonhardt SA; Edwards DP
Exp Biol Med (Maywood); 2002 Dec; 227(11):969-80. PubMed ID: 12486206
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptor and the mechanism of action of progesterone antagonists.
Edwards DP; Altmann M; DeMarzo A; Zhang Y; Weigel NL; Beck CA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):449-58. PubMed ID: 7626494
[TBL] [Abstract][Full Text] [Related]
23. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.
Schulz M; Eggert M; Baniahmad A; Dostert A; Heinzel T; Renkawitz R
J Biol Chem; 2002 Jul; 277(29):26238-43. PubMed ID: 12011091
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor antagonism by cyproterone acetate and RU486.
Honer C; Nam K; Fink C; Marshall P; Ksander G; Chatelain RE; Cornell W; Steele R; Schweitzer R; Schumacher C
Mol Pharmacol; 2003 May; 63(5):1012-20. PubMed ID: 12695529
[TBL] [Abstract][Full Text] [Related]
25. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
26. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
[TBL] [Abstract][Full Text] [Related]
27. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
Baulieu EE
Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
[TBL] [Abstract][Full Text] [Related]
28. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
[TBL] [Abstract][Full Text] [Related]
29. Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism.
Lee MS; Choi HS; Kwon SH; Morita K; Her S
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):67-73. PubMed ID: 19635558
[TBL] [Abstract][Full Text] [Related]
30. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Liu Z; Auboeuf D; Wong J; Chen JD; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7940-4. PubMed ID: 12048256
[TBL] [Abstract][Full Text] [Related]
31. RU486 (mifepristone): mechanisms of action and clinical uses.
Cadepond F; Ulmann A; Baulieu EE
Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
[TBL] [Abstract][Full Text] [Related]
32. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail.
Allan GF; Lombardi E; Haynes-Johnson D; Palmer S; Kiddoe M; Kraft P; Campen C; Rybczynski P; Combs DW; Phillips A
Mol Endocrinol; 1996 Oct; 10(10):1206-13. PubMed ID: 9121488
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: evidence for the involvement of DNA-binding and agonistic effects of the antiglucocorticoid/antiprogestin RU486.
Cairns C; Cairns W; Okret S
DNA Cell Biol; 1993 Oct; 12(8):695-702. PubMed ID: 8397827
[TBL] [Abstract][Full Text] [Related]
34. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
[TBL] [Abstract][Full Text] [Related]
35. A new strategy for selective targeting of progesterone receptor with passive antagonists.
Khan JA; Tikad A; Fay M; Hamze A; Fagart J; Chabbert-Buffet N; Meduri G; Amazit L; Brion JD; Alami M; Lombès M; Loosfelt H; Rafestin-Oblin ME
Mol Endocrinol; 2013 Jun; 27(6):909-24. PubMed ID: 23579486
[TBL] [Abstract][Full Text] [Related]
36. The molecular basis of RU486 resistance in the Tammar Wallaby, Macropus eugenii.
Lim-Tio SS; Keightley MC; Fletcher TP; Fuller PJ
Mol Cell Endocrinol; 1996 May; 119(2):169-74. PubMed ID: 8807636
[TBL] [Abstract][Full Text] [Related]
37. [Effects of the antagonist of the classical progesterone receptor on ovulation and maturation of common frog (Rana temporaria L.) oocytes in vitro].
Skoblina MN
Ontogenez; 2002; 33(6):465-70. PubMed ID: 12500556
[TBL] [Abstract][Full Text] [Related]
38. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
[TBL] [Abstract][Full Text] [Related]
39. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
Shatnawi A; Tran T; Ratnam M
Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
[TBL] [Abstract][Full Text] [Related]
40. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor.
Xu J; Nawaz Z; Tsai SY; Tsai MJ; O'Malley BW
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12195-9. PubMed ID: 8901556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
